How much funding has Icardio.AI raised?

Icardio.AI has raised $5.6M in total funding, most recently a Corporate Round.

Who are Icardio.AI's investors?

Icardio.AI's investors include Techstars, Boomerang Ventures, The Roddenberry Foundation, Cove Fund II, Cedars-Sinai Accelerator.

When was Icardio.AI founded?

Icardio.AI was founded in 2023.

Where is Icardio.AI headquartered?

Icardio.AI is headquartered in Los Angeles, California, United States.

What industry is Icardio.AI in?

Icardio.AI operates in Healthcare.

How many employees does Icardio.AI have?

Icardio.AI has 11-50 employees.

Icardio.AI

AI echo analysis, in a heartbeat.

Los Angeles, United States · Founded 2023 · $5.6M raised

Healthcare

Headquarters: Los Angeles, California
Employees: 11–50
Founded: 2023
Business Model: B2B

Website: icardio.ai
Total Funding: $5.6M
Last Round: $4.5M Corporate RoundJan 2025
Rounds: 3

About

iCardio.ai develops AI for ultrasound imaging interpretation with a focus on echocardiograms. Built on a proprietary dataset of over 200M annotated ultrasound images, the platform serves leading ultrasound hardware and software companies including GE Healthcare. Their FDA-cleared CardioVision™ product automates aortic stenosis detection from standard echo and handheld devices.

Summary

Icardio.AI is a Healthcare company based in Los Angeles, United States, founded in 2023. It has raised $5.6M in total across 3 rounds, most recently a $4.5M Corporate Round round in Jan 2025. Investors include Techstars, Boomerang Ventures and The Roddenberry Foundation.